Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

BHC stock rises 14.7% in a week after a report surfaced that the company is in talks with Jefferies Financial Group to push ...

Bausch + Lomb Corp (NYSE:BLCO) is reportedly considering a sale as it navigates separation issues from its parent company, ...

Gibbons and Venable filed a patent infringement lawsuit on Sept. 18 in New Jersey District Court on behalf of Bausch & Lomb Inc. The court action, which targets PRN Physician Recommended ...

Eye-care company is working with Goldman Sachs on a deal that would extricate it from its indebted parent, the Financial ...

18 in New Jersey District Court on behalf of Bausch & Lomb Americas Inc. and other plaintiffs. The suit names Lipotriad LLC and PRN Physician Recommended Nutriceuticals for allegedly using the ...

Analyst Glen Santangelo of Jefferies reiterated a Buy rating on Bausch Health Companies (BHC – Research Report), reducing the price ...

Bausch + Lomb Corporation (T.BLCO) hit a new 52-week high of $27.36 Wednesday. No news stories available today. Calibre ...

Bausch + Lomb is headed by Brent Saunders, a longtime pharmaceutical executive known for leading Allergan into a much-hyped but failed $160 billion merger with Pfizer Inc. (PFE) in 2015 and then ...

The potential sale is part of efforts to address concerns from creditors like Apollo Global Management Inc APO following disputes over the separation. The Bausch + Lomb spin-off was part of Bausch ...

Trukera Medical, whose executive chairman is well-known Orange County executive Jim Mazzo, announced last month that it has been acquired by global eye health company Bausch + Lomb Corp. for an ...